HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Edward D. Verrier Michael S. Mulligan Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Naidu, B. V. Articles by Mulligan, M. S. Search for Related Content PubMed PubMed Citation Articles by Naidu, B. V. Articles by Mulligan, M. S.

Ann Thorac Surg 2002;74:899-905
© 2002 The Society of Thoracic Surgeons

---

Original article: general thoracic

Regulation of chemokine expression by cyclosporine a in alveolar macrophages exposed to hypoxia and reoxygenation

^a Division of Cardiothoracic Surgery, University of Washington, Seattle, WA, USA

* Address reprint requests to Dr Mulligan, Division of Cardiothoracic Surgery, Box 356310, 1959 NE Pacific St, University of Washington, Seattle, WA 09195 USA
e-mail: msmdu{at}uwashington.edu

Presented at the Thirty-eighth Annual Meeting of The Society of Thoracic Surgeons, Fort Lauderdale, FL, January 28–30, 2002.

Background. We have recently demonstrated a role for selected chemokines in a rat model of lung ischemia reperfusion injury (LIRI). We have further shown that pretreatment with cyclosporine A (CSA) is protective. The precise cellular events regulating this model are unknown. The alveolar macrophage (AM) is a key effector cell in multiple models of acute lung injury, and it likely plays a central role in LIRI as well. The present studies were undertaken to determine whether CSA functions in part by modifying the chemokine response of AMs to hypoxia and reoxygenation in vitro.

Methods. Alveola macrophages were rendered hypoxic (0.5%) for 2 hours and reoxygenated for 6 hours. The secreted chemokine content in the media was quantified by enzyme-linked immunosorbent assay, and nuclear protein was analyzed after electro-mobility shift assay. When employed, CSA was administered 30 minutes before hypoxia.

Results. Alveolar macrophages demonstrated a marked increase in the secretion of the chemokines, MIP-2, MIP-1, CINC, and MCP-1, in response to hypoxia and reoxygenation. This increase was dependent on mRNA transcription and de novo protein synthesis. It was also blocked by a specific inhibitor of the nuclear translocation factor, NF-B. Pretreatment with CSA (500 ng/mL) significantly reduced expression of chemokines and activation of NF-B.

Conclusions. Cyclosporine A attenuates the chemokine response of AMs in vitro to hypoxia and reoxygenation at the pretranscriptional level through modulation of NF-B. These findings suggest the potential mechanism of action of CSA’s protective effects in lung ischemia reperfusion injury.

This article has been cited by other articles:

				P. S. Wolf, H. E. Merry, A. S. Farivar, A. S. McCourtie, and M. S. Mulligan Stress-activated protein kinase inhibition to ameliorate lung ischemia reperfusion injury J. Thorac. Cardiovasc. Surg., March 1, 2008; 135(3): 656 - 665. [Abstract] [Full Text] [PDF]

				A. S. McCourtie, H. E. Merry, A. S. Farivar, C. H. Goss, and M. S. Mulligan Alveolar Macrophage Secretory Products Augment the Response of Rat Pulmonary Artery Endothelial Cells to Hypoxia and Reoxygenation Ann. Thorac. Surg., March 1, 2008; 85(3): 1056 - 1060. [Abstract] [Full Text] [PDF]

				M. Zhao, L. G. Fernandez, A. Doctor, A. K. Sharma, A. Zarbock, C. G. Tribble, I. L. Kron, and V. E. Laubach Alveolar macrophage activation is a key initiation signal for acute lung ischemia-reperfusion injury Am J Physiol Lung Cell Mol Physiol, November 1, 2006; 291(5): L1018 - L1026. [Abstract] [Full Text] [PDF]

				A. S. Farivar, H. E. Merry, M. J. Fica-Delgado, A. S. McCourtie, B. C. Mackinnon-Patterson, and M. S. Mulligan Interleukin-6 Regulation of Direct Lung Ischemia Reperfusion Injury Ann. Thorac. Surg., August 1, 2006; 82(2): 472 - 478. [Abstract] [Full Text] [PDF]

				A. S. Farivar, B. C. Mackinnon-Patterson, A. D. Barnes, A. S. McCourtie, and M. S. Mulligan Cyclosporine Modulates the Response to Hypoxia-Reoxygenation in Pulmonary Artery Endothelial Cells Ann. Thorac. Surg., March 1, 2005; 79(3): 1010 - 1016. [Abstract] [Full Text] [PDF]

				B. V. Naidu, S. M. Woolley, A. S. Farivar, R. Thomas, C. H. Fraga, C. H. Goss, and M. S. Mulligan Early tumor necrosis factor-{alpha} release from the pulmonary macrophage in lung ischemia-reperfusion injury J. Thorac. Cardiovasc. Surg., May 1, 2004; 127(5): 1502 - 1508. [Abstract] [Full Text] [PDF]

				S. M. Woolley, A. S. Farivar, B. V. Naidu, M. Rosengart, R. Thomas, C. Fraga, and M. S. Mulligan Endotracheal calcineurin inhibition ameliorates injury in an experimental model of lung ischemia-reperfusion J. Thorac. Cardiovasc. Surg., February 1, 2004; 127(2): 376 - 384. [Abstract] [Full Text] [PDF]

				B. V. Naidu, B. Krishnadasan, A. S. Farivar, S. M. Woolley, R. Thomas, N. Van Rooijen, E. D. Verrier, and M. S. Mulligan Early activation of the alveolar macrophage is critical to the development of lung ischemia-reperfusion injury J. Thorac. Cardiovasc. Surg., July 1, 2003; 126(1): 200 - 207. [Abstract] [Full Text] [PDF]

				M. de Perrot, M. Liu, T. K. Waddell, and S. Keshavjee Ischemia-Reperfusion-induced Lung Injury Am. J. Respir. Crit. Care Med., February 15, 2003; 167(4): 490 - 511. [Abstract] [Full Text] [PDF]